GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 86 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 53 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 46 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FLGB | GSK | |
---|---|---|
RSI ODDS (%) | N/A | 4 days ago50% |
Stochastic ODDS (%) | 4 days ago75% | 4 days ago36% |
Momentum ODDS (%) | 4 days ago82% | 4 days ago61% |
MACD ODDS (%) | 4 days ago82% | 4 days ago67% |
TrendWeek ODDS (%) | 4 days ago83% | 4 days ago61% |
TrendMonth ODDS (%) | 4 days ago80% | 4 days ago53% |
Advances ODDS (%) | 6 days ago83% | 6 days ago59% |
Declines ODDS (%) | 12 days ago74% | 4 days ago52% |
BollingerBands ODDS (%) | 4 days ago84% | 4 days ago48% |
Aroon ODDS (%) | 4 days ago82% | 4 days ago48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HKND | 35.21 | 0.26 | +0.74% |
Humankind US Stock ETF | |||
EMSF | 30.00 | 0.12 | +0.39% |
Matthews Emerging Markets Sus Fut ActETF | |||
CGGE | 31.19 | 0.11 | +0.35% |
Capital Group Global Equity ETF | |||
VUSE | 66.65 | 0.02 | +0.03% |
Vident U.S. Equity Strategy ETF | |||
KWEB | 42.65 | -0.29 | -0.68% |
KraneShares CSI China Internet ETF |
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.